John Danhakl - IQVIA Holdings Independent Director
IQV Stock | USD 145.55 2.33 1.63% |
Director
Mr. John G. Danhakl is Independent Director of the Company since October 2016. Prior to his role at the Company, Mr. Danhakl served as a director of IMS Health from February 2010 until October 2016. He is Managing Partner at LGP, which he joined in 1995. Previously, Mr. Danhakl was a Managing Director of Donaldson, Lufkin Jenrette Securities Corporationrationration, which he joined in 1990. From 1985 until 1990, Mr. Danhakl was a Vice President in corporate finance at Drexel Burnham Lambert, Inc. Mr. Danhakl currently serves on the boards of directors of Advantage Solutions, Inc., Charter NEX, Global Citizen, CPA Global, Genani Corporationrationration, Insight Global, Inc., Life Time Fitness, Inc., Mister Car Wash Holdings, Inc., MultiPlan, Inc., Savers, Inc. and SRS Distribution. He previously served on the boards of directors of Air Lease Corporationrationration, Animal Health, Inc., Arden Group, Inc., AsianMedia Group, LLC, Big 5 Sporting Goods Corporationrationration, CCC Information Services, Inc., Communications Power Industries, Inc., Diamond Triumph Auto Glass, Inc., Hits, Inc., J. Crew Group, Inc., Leslies Poolmart, Inc., Liberty Group Publishing, Inc., SunEdison Inc., Packers Sanitation Services, Inc., Petco Animal Supplies, Inc., Phoenix Scientific, Inc., Rite Aid Corporationrationration, Sagittarius Brands, The Neiman Marcus Group, Tire Rack, Inc. and VCA Antech, Inc since 2016.
Age | 64 |
Tenure | 9 years |
Professional Marks | MBA |
Address | 2400 Ellis Road, Durham, NC, United States, 27703 |
Phone | 919 998 2000 |
Web | https://www.iqvia.com |
John Danhakl Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Danhakl against IQVIA Holdings stock is an integral part of due diligence when investing in IQVIA Holdings. John Danhakl insider activity provides valuable insight into whether IQVIA Holdings is net buyers or sellers over its current business cycle. Note, IQVIA Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell IQVIA Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Danhakl over three months ago Acquisition by John Danhakl of 135 shares of IQVIA Holdings subject to Rule 16b-3 |
IQVIA Holdings Management Efficiency
The company has Return on Asset of 0.0532 % which means that on every $100 spent on assets, it made $0.0532 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2255 %, implying that it generated $0.2255 on every 100 dollars invested. IQVIA Holdings' management efficiency ratios could be used to measure how well IQVIA Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IQVIA Holdings' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to climb to 0.06 in 2025, whereas Return On Tangible Assets are likely to drop 0.1 in 2025. At this time, IQVIA Holdings' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 465.9 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 14.3 B in 2025.Similar Executives
Showing other executives | DIRECTOR Age | ||
WahHui Chu | Mettler Toledo International | 69 | |
George Llado | Charles River Laboratories | 55 | |
Virginia Wilson | Charles River Laboratories | 66 | |
Richard Francis | Mettler Toledo International | 52 | |
Robert Bertolini | Charles River Laboratories | 59 | |
Edward Conard | Waters | 63 | |
Thomas Salice | Mettler Toledo International | 61 | |
Jeffrey Davis | Laboratory of | 57 | |
Kerrii Anderson | Laboratory of | 63 | |
JeanLuc Belingard | Laboratory of | 72 | |
Michael Kelly | Mettler Toledo International | 64 | |
Gary Hendrickson | Waters | 64 | |
George Milne | Charles River Laboratories | 77 | |
Martin Mackay | Charles River Laboratories | 65 | |
George Massaro | Charles River Laboratories | 73 | |
Peter Neupert | Laboratory of | 65 | |
Richelle Parham | Laboratory of | 53 | |
Robert Williams | Laboratory of | 72 | |
Richard Reese | Charles River Laboratories | 75 | |
Elisha Finney | Mettler Toledo International | 59 | |
Richard Wallman | Charles River Laboratories | 69 |
Management Performance
Return On Equity | 0.23 | ||||
Return On Asset | 0.0532 |
IQVIA Holdings Leadership Team
Elected by the shareholders, the IQVIA Holdings' board of directors comprises two types of representatives: IQVIA Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IQVIA. The board's role is to monitor IQVIA Holdings' management team and ensure that shareholders' interests are well served. IQVIA Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IQVIA Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Ari Bousbib, Chairman of the Board, President, Chief Executive Officer | ||
Nicholas Childs, Senior Treasury | ||
John Danhakl, Independent Director | ||
Trudy Stein, Chief VP | ||
Andrea Spannheimer, Global Research | ||
Richard III, President Solutions | ||
Walter Staub, President - Research and Development Solutions | ||
Michael McDonnell, Chief Financial Officer, Executive Vice President | ||
Andrew Markwick, VP Relations | ||
Carol Burt, Independent Director | ||
Jon Resnick, President Canada | ||
John Leonard, Lead Independent Director | ||
BBS ACMA, Chief Laboratories | ||
Keriann Cherofsky, Corporate VP | ||
Gregg Dearhammer, Safety Sciences | ||
Cynthia Verst, President Innovation | ||
Jeffrey MD, Global VP | ||
James Fasano, Independent Director | ||
Ronald Bruehlman, Interim Chief Financial Officer, Executive Vice President | ||
Jeffrey Spaeder, Global VP | ||
Eric JD, General VP | ||
John Connaughton, Independent Director | ||
Colleen Goggins, Independent Director | ||
Nilton Paletta, President America | ||
Todd Sisitsky, Independent Director | ||
Bhavik Patel, President IQVIA | ||
Eric Sherbet, Executive Vice President General Counsel, Secretary | ||
Costa Panagos, President - Research & Development Solutions | ||
Lucas Glass, Global Excellence | ||
Rob Kotchie, President Solutions | ||
Wendy Stewart, President Operations | ||
Kerri Joseph, SVP Treasury | ||
Jim Berkshire, Executive Operations | ||
Alistair Grenfell, Middle Europe | ||
Karl Guenault, Senior Officer | ||
Ronald Rittenmeyer, Independent Director | ||
Brian Mi, President Pacific | ||
Kevin Knightly, President - Information and Technology Solutions |
IQVIA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IQVIA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.23 | ||||
Return On Asset | 0.0532 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 37.56 B | ||||
Shares Outstanding | 176.32 M | ||||
Shares Owned By Insiders | 0.88 % | ||||
Shares Owned By Institutions | 95.83 % | ||||
Number Of Shares Shorted | 3.81 M | ||||
Price To Earning | 103.68 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IQVIA Stock Analysis
When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.